TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
852,867
Share change
-5,020,555
Total reported value
$150,000
Price per share
$0.17
Number of holders
18
Value change
-$9,140,896
Number of buys
9
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q1 2016

As of 31 Mar 2016, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 852,867 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, LAZARD ASSET MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Geneva Advisors, LLC, TWO SIGMA SECURITIES, LLC, MORGAN STANLEY, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and Bank of New York Mellon Corp. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.